Overview

  • Product name

    Lithium chloride, GSK3beta inhibitor
  • Description

    GSK3β inhibitor
  • Biological description

    Direct, non-competitive GSK3β inhibitor in vitro (Ki = 2 mM). Elicits various neuropharmacological effects.
  • Purity

    > 99%
  • CAS Number

    7447-41-8
  • Chemical structure

    Chemical Structure

Properties

References

This product has been referenced in:

  • Makoukji J  et al. Lithium enhances remyelination of peripheral nerves. Proc Natl Acad Sci U S A 109:3973-8 (2012). Read more (PubMed: 22355115) »
  • Pan JQ  et al. AKT kinase activity is required for lithium to modulate mood-related behaviors in mice. Neuropsychopharmacology 36:1397-411 (2011). Read more (PubMed: 21389981) »
  • Zhu Q  et al. Suppression of glycogen synthase kinase 3 activity reduces tumor growth of prostate cancer in vivo. Prostate 71:835-45 (2011). Read more (PubMed: 21456066) »
  • Klein PS & Melton DA A molecular mechanism for the effect of lithium on development. Proc Natl Acad Sci U S A 93:8455-9 (1996). Read more (PubMed: 8710892) »
See 1 Publication for this product

Customer reviews and Q&As

There are currently no Customer reviews or Questions for ab120853.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES, NOT FOR USE IN HUMANS"
For licensing inquiries, please contact partnerships@abcam.com

Sign up